Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Benaglutide in Overweight/Obese Adults
NCT05226000Phase 1Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of beinaglutide in obesity and Overweight, sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Peak Plasma Concentration at 80 days, Area under the plasma concentration versus time curve from time zero to time t at 80 days and 3 more. Started Jul 2020; status: completed.
02
Drugs
beinaglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT05226000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05226000.